论文部分内容阅读
目的:对慢性支气管炎患者运用盐酸氨溴索注射液治疗,探讨与分析临床疗效。方法:本研究共纳入研究对象44例,均为2013年2月到2014年2月我院收治的慢性支气管炎患者,在征得患者同意的基础上依照随机数字表的方式给予其中22例临床常规对症与支持疗法(B组),另22例给予盐酸氨溴索注射液治疗(A组),对两组的临床治疗效果进行观察与对比。结果:经相应治疗,在总有效率上,A组达到了95.5%(21/22),B组为77.3%(17/22),A组显著高于B组(P<0.05)。结论:对于慢性支气管炎患者来说,在常规处理上配合使用盐酸氨溴索注射液可起到显著的治疗效果,安全无毒副作用,有着较好的用药安全性,有着重要的临床使用价值。
Objective: To treat patients with chronic bronchitis with ambroxol hydrochloride injection, to explore and analyze the clinical efficacy. Methods: A total of 44 study subjects were enrolled in this study, all from February 2013 to February 2014 in our hospital for chronic bronchitis patients, with the consent of patients on the basis of random number table to give them 22 cases of clinical Conventional symptomatic and supportive therapy (group B), the other 22 patients were given ambroxol hydrochloride injection (group A), the clinical treatment of both groups were observed and compared. Results: After treatment, the total effective rate was 95.5% (21/22) in group A, 77.3% (17/22) in group B, and significantly higher in group A than in group B (P <0.05). Conclusion: For patients with chronic bronchitis, ambroxol hydrochloride injection can play a significant therapeutic effect in routine treatment with safe and nontoxic side effects, good drug safety and important clinical value.